Recent developments in HIV protease inhibitor therapy
- 1 July 1998
- journal article
- review article
- Published by Elsevier in Antiviral Research
- Vol. 39 (1) , 1-23
- https://doi.org/10.1016/s0166-3542(98)00011-4
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical TrialsJournal of Biological Chemistry, 1996
- A 24-week open-label Phase I/II evaluation of the HIV protease inhibitor MK-639 (indinavir)AIDS, 1996
- HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation TimeScience, 1996
- Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)AIDS, 1996
- Resistance of HIV Type 1 to Proteinase Inhibitor Ro 31-8959AIDS Research and Human Retroviruses, 1995
- In vivo emergence of HIV-1 variants resistant to multiple protease inhibitorsNature, 1995
- Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infectionNature, 1995
- Viral dynamics in human immunodeficiency virus type 1 infectionNature, 1995
- Comparison of the HIV‐1 and HIV‐2 proteinases using oligopeptide substrates representing cleavage sites in Gag and Gag‐Pol polyproteinsFEBS Letters, 1991
- HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteinsBiochemical and Biophysical Research Communications, 1988